Literature DB >> 10531266

De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model.

I W Fong1, B Chiu, E Viira, D Jang, J B Mahony.   

Abstract

Chlamydia pneumoniae, a bacterial respiratory tract pathogen, has been associated with atherosclerosis in humans. C. pneumoniae infection of the respiratory tracts of rabbits fed a noncholesterol diet induced changes of atherosclerosis of the aorta in 6 (26.1%) of 23 animals after a single inoculum at 3 months. Multiple inocula given three times within 6 weeks resulted in grade III atherosclerosis in 8 (34.8%) of 23 rabbits, with an additional 5 (21. 7%) showing increased myxoid changes in the intima-media junction and exhibiting 8 (34.8%) focal periaortitis. Control animals inoculated with carrier broth (n = 24), HEp-2 cells (n = 12), or another respiratory pathogen, Mycoplasma pneumoniae (n = 32), produced no changes of atherosclerosis after 3 months. The histological changes were dissimilar (fewer foam cells) from those of rabbits fed a 0.5% cholesterol diet but were highly similar to or indistinguishable from changes in rabbits fed a 0.15% cholesterol diet (similar to that of humans). Proinflammatory cytokines and tissue growth factors were more consistently detected in cholesterol-induced aortic lesions than those induced by C. pneumoniae. These data are compatible with de novo induction of atherogenesis by C. pneumoniae in rabbits and suggest that C. pneumoniae may be important in the pathogenesis of atherosclerosis in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531266      PMCID: PMC96992     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Rabbit model for Chlamydia pneumoniae infection.

Authors:  I W Fong; B Chiu; E Viira; M W Fong; D Jang; J Mahony
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

2.  Murine models of Chlamydia pneumoniae infection and atherosclerosis.

Authors:  T C Moazed; C Kuo; J T Grayston; L A Campbell
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

3.  Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression.

Authors:  A Kol; G K Sukhova; A H Lichtman; P Libby
Journal:  Circulation       Date:  1998-07-28       Impact factor: 29.690

4.  Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease.

Authors:  E Linnanmäki; M Leinonen; K Mattila; M S Nieminen; V Valtonen; P Saikku
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

5.  Cholesterol-fed and casein-fed rabbit models of atherosclerosis. Part 2: Differing morphological severity of atherogenesis despite matched plasma cholesterol levels.

Authors:  S J Daley; K F Klemp; J R Guyton; K A Rogers
Journal:  Arterioscler Thromb       Date:  1994-01

6.  Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain.

Authors:  C C Kuo; A M Gown; E P Benditt; J T Grayston
Journal:  Arterioscler Thromb       Date:  1993-10

7.  Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Authors:  S L Melnick; E Shahar; A R Folsom; J T Grayston; P D Sorlie; S P Wang; M Szklo
Journal:  Am J Med       Date:  1993-11       Impact factor: 4.965

8.  Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis.

Authors:  J T Grayston; M B Aldous; A Easton; S P Wang; C C Kuo; L A Campbell; J Altman
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

9.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.

Authors:  C C Kuo; A Shor; L A Campbell; H Fukushi; D L Patton; J T Grayston
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

Review 10.  The pathogenesis of atherosclerosis: a perspective for the 1990s.

Authors:  R Ross
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

View more
  29 in total

1.  Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells.

Authors:  J B Mahony; S Chong; B K Coombes; M Smieja; A Petrich
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic mice.

Authors:  K Burian; K Berencsi; V Endresz; Z Gyulai; T Valyi-Nagy; I Valyi-Nagy; M Bakay; Y Geng; D Virok; L Kari; R Hajnal-Papp; G Trinchieri; E Gonczol
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

3.  Chlamydia pneumoniae infected macrophages exhibit enhanced plasma membrane fluidity and show increased adherence to endothelial cells.

Authors:  Anthony A Azenabor; Godwin Job; Olanrewaju O Adedokun
Journal:  Mol Cell Biochem       Date:  2005-01       Impact factor: 3.396

4.  Development of a hamster model of Chlamydophila pneumoniae infection.

Authors:  A Marangoni; V Sambri; M Donati; K Di Leo; R Cevenini
Journal:  Vet Res Commun       Date:  2005-03       Impact factor: 2.459

Review 5.  Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested.

Authors:  J Thomas Grayston; Robert J Belland; Gerald I Byrne; Cho Chou Kuo; Julius Schachter; Walter E Stamm; Guangming Zhong
Journal:  Pathog Dis       Date:  2014-12-04       Impact factor: 3.166

6.  Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model.

Authors:  Ignatius W Fong; Brian Chiu; Esther Viira; Dan Jang; James B Mahony
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

7.  Chlamydophila pneumoniae infection leads to smooth muscle cell proliferation and thickening in the coronary artery without contributions from a host immune response.

Authors:  Justin F Deniset; Paul K M Cheung; Elena Dibrov; Kaitlin Lee; Sarah Steigerwald; Grant N Pierce
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

8.  Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Hannu Alakärppä; Denise Bem David; Maija Leinonen; Pekka Saikku
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  New perspectives of infections in cardiovascular disease.

Authors:  Ignatius W Fong
Journal:  Curr Cardiol Rev       Date:  2009-05

10.  Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.

Authors:  Sueli B Damy; Maria L Higuchi; Jorge Timenetsky; Márcia M Reis; Suely P Palomino; Renata N Ikegami; Fabiana P Santos; Junko T Osaka; Luiz P Figueiredo
Journal:  BMC Microbiol       Date:  2009-09-10       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.